UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2025
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 001-35992
Oracle Corporation
(Exact name of registrant as specified in its charter)
Delaware
54-2185193
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2300 Oracle Way
Austin, Texas
78741
(Address of principal executive offices)
(Zip Code)
(737) 867-1000
(Registrant s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
ORCL
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The number of shares of registrant s common stock outstanding as of December 5, 2025 was: 2,873,130,000.
Table of Contents
ORACLE CORPORATION
FORM 10-Q QUARTERLY REPORT
TABLE OF CONTENTS
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of November 30, 2025 and May 31, 2025
Condensed Consolidated Statements of Operations for the Three and Six Months Ended November 30, 2025 and 2024
Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended November 30, 2025 and 2024
Condensed Consolidated Statements of Stockholders Equity for the Three and Six Months Ended November 30, 2025 and 2024
Condensed Consolidated Statements of Cash Flows for the Six Months Ended November 30, 2025 and 2024
Notes to Condensed Consolidated Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
20
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
38
Item 4.
Controls and Procedures
38
PART II.
OTHER INFORMATION
39
Item 1.
Legal Proceedings
39
Item 1A.
Risk Factors
39
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
39
Item 5.
Other Information
40
Item 6.
Exhibits
41
Signatures
43
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
ORACLE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
As of November 30, 2025 and May 31, 2025
(Unaudited)
(in millions, except per share data)
November 30,
2025
May 31,
2025
ASSETS
Current assets:
Cash and cash equivalents
19,241
10,786
Marketable securities
525
417
Trade receivables, net of allowances for credit losses of $539 and $557 as of November 30, 2025 and May 31, 2025, respectively
9,440
8,558
Prepaid expenses and other current assets
5,160
4,818
Total current assets
34,366
24,579
Non-current assets:
Property, plant and equipment, net
67,875
43,522
Intangible assets, net
3,760
4,587
Goodwill
62,207
62,207
Deferred tax assets
11,531
11,877
Other non-current assets
25,245
21,589
Total non-current assets
170,618
143,782
Total assets
204,984
168,361
LIABILITIES AND STOCKHOLDERS EQUITY
Current liabilities:
Notes payable and other borrowings, current
8,091
7,271
Accounts payable
10,140
5,113
Accrued compensation and related benefits
1,947
2,243
Deferred revenues
9,940
9,387
Other current liabilities
7,677
8,629
Total current liabilities
37,795
32,643
Non-current liabilities:
Notes payable and other borrowings, non-current
99,984
85,297
Income taxes payable
10,885
10,269
Operating lease liabilities
16,311
11,536
Other non-current liabilities
9,552
7,647
Total non-current liabilities
136,732
114,749
Commitments and contingencies
Oracle Corporation stockholders equity:
Preferred stock, $0.01 par value authorized: 1.0 shares; outstanding: none
Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares; outstanding: 2,873 shares and 2,807 shares as of November 30, 2025 and May 31, 2025, respectively
40,577
37,107
Accumulated deficit
(9,355
(15,481
Accumulated other comprehensive loss
(1,271
(1,175
Total Oracle Corporation stockholders equity
29,951
20,451
Noncontrolling interests
506
518
Total stockholders equity
30,457
20,969
Total liabilities and stockholders equity
204,984
168,361
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Six Months Ended November 30, 2025 and 2024
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2025
2024
2025
2024
Revenues:
Cloud
7,977
5,937
15,162
11,559
Software
5,877
6,064
11,598
11,830
Hardware
776
728
1,446
1,383
Services
1,428
1,330
2,777
2,594
Total revenues
16,058
14,059
30,983
27,366
Operating expenses:
Cloud and software(1)
3,990
2,746
7,597
5,344
Hardware(1)
215
172
393
333
Services(1)
1,169
1,167
2,268
2,314
Sales and marketing(1)
2,149
2,190
4,211
4,226
Research and development
2,561
2,471
5,051
4,777
General and administrative
409
387
786
745
Amortization of intangible assets
407
591
826
1,215
Acquisition related and other
21
31
35
44
Restructuring
406
84
808
157
Total operating expenses
11,327
9,839
21,975
19,155
Operating income
4,731
4,220
9,008
8,211
Interest expense
(1,057
(866
(1,980
(1,708
Non-operating income, net
2,668
36
2,741
57
Income before income taxes
6,342
3,390
9,769
6,560
Provision for income taxes
207
239
707
480
Net income
6,135
3,151
9,062
6,080
Earnings per share:
Basic
2.14
1.13
3.19
2.19
Diluted
2.10
1.10
3.11
2.13
Weighted average common shares outstanding:
Basic
2,864
2,790
2,845
2,775
Diluted
2,922
2,869
2,916
2,860
(1)Exclusive of amortization of intangible assets, which is shown separately.
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the Three and Six Months Ended November 30, 2025 and 2024
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2025
2024
2025
2024
Net income
6,135
3,151
9,062
6,080
Other comprehensive loss, net of tax:
Net foreign currency translation (losses) gains
(90
(217
(62
Net unrealized (losses) gains on cash flow hedges
(9
28
(33
(88
Other, net
(2
(2
(1
(2
Total other comprehensive loss, net
(101
(191
(96
(87
Comprehensive income
6,034
2,960
8,966
5,993
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
For the Three and Six Months Ended November 30, 2025 and 2024
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2025
2024
2025
2024
Common stock and additional paid in capital
Balance, beginning of period
39,378
33,083
37,107
32,764
Common stock issued
138
128
1,308
307
Stock-based compensation
1,156
1,170
2,280
2,176
Repurchases of common stock
(11
(6
(24
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(92
(47
(109
(898
Other, net
(3
(13
(3
(15
Balance, end of period
40,577
34,310
40,577
34,310
Accumulated deficit
Balance, beginning of period
(14,054
(20,939
(15,481
(22,628
Repurchases of common stock
(139
(87
(276
Cash dividends declared
(1,436
(1,118
(2,848
(2,221
Net income
6,135
3,151
9,062
6,080
Other, net
(1
Balance, end of period
(9,355
(19,045
(9,355
(19,045
Other stockholders equity, net
Balance, beginning of period
(658
(875
(657
(897
Other comprehensive loss, net
(101
(191
(96
(87
Other, net
(6
37
(12
(45
Balance, end of period
(765
(1,029
(765
(1,029
Total stockholders equity
30,457
14,236
30,457
14,236
Cash dividends declared per common share
0.50
0.40
1.00
0.80
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ended November 30, 2025 and 2024
(Unaudited)
Six Months Ended
November 30,
(in millions)
2025
2024
Cash flows from operating activities:
Net income
9,062
6,080
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
3,055
1,712
Amortization of intangible assets
826
1,215
Deferred income taxes
332
(601
Stock-based compensation
2,280
2,176
Gains from investments and other, net
(2,227
298
Changes in operating assets and liabilities:
Increase in trade receivables, net
(900
(451
Decrease in prepaid expenses and other assets
1,285
676
Decrease in accounts payable and other liabilities
(1,366
(1,143
Decrease in income taxes payable
(2,608
(1,685
Increase in deferred revenues
467
454
Net cash provided by operating activities
10,206
8,731
Cash flows from investing activities:
Purchases of marketable securities and other investments
(634
(636
Proceeds from sales and maturities of marketable securities and other investments
4,737
356
Capital expenditures
(20,535
(6,273
Net cash used for investing activities
(16,432
(6,553
Cash flows from financing activities:
Payments for repurchases of common stock
(95
(300
Proceeds from issuances of common stock
1,308
307
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(109
(898
Payments of dividends to stockholders
(2,848
(2,221
Proceeds from (repayments of) commercial paper and other short-term financing, net
886
(396
Proceeds from issuances of senior notes and term loan credit agreements, net of issuance costs
17,880
11,837
Repayments of senior notes, term loan credit agreements and other borrowings
(2,122
(9,700
Other financing activities, net
(203
(276
Net cash provided by (used for) financing activities
14,697
(1,647
Effect of exchange rate changes on cash and cash equivalents
(16
(44
Net increase in cash and cash equivalents
8,455
487
Cash and cash equivalents at beginning of period
10,786
10,454
Cash and cash equivalents at end of period
19,241
10,941
Non-cash investing activities:
Unpaid capital expenditures
6,849
2,086
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
November 30, 2025
(Unaudited)
1.BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER
Basis of Presentation
We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the United States (U.S.) Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025.
We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending May 31, 2026. We reclassed certain revenues and other related disclosures to conform to the current period s presentation for all periods presented in our condensed consolidated statements of operations. Such reclassifications did not affect total revenue, income from operations or net income.
There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the six months ended November 30, 2025.
Cash, Cash Equivalents and Restricted Cash
Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of November 30, 2025 and May 31, 2025 and our condensed consolidated statements of cash flows for the six months ended November 30, 2025 and 2024 was immaterial.
Remaining Performance Obligations from Contracts with Customers
Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of November 30, 2025 and May 31, 2025. The revenues recognized during the six months ended November 30, 2025 and 2024 that were included in the opening deferred revenues balances as of May 31, 2025 and 2024 were approximately $7.0 billion and $6.9 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and six months ended November 30, 2025 and 2024, respectively.
Remaining performance obligations were $523.3 billion as of November 30, 2025, of which we expect to recognize approximately 10% as revenues over the next twelve months, 30% over the subsequent month 13 to month 36, 35% over the subsequent month 37 to month 60 and the remainder thereafter. We have elected the optional exemption to not disclose the variable consideration for contracts in which the variable consideration expected to be received over the duration of the contract is allocated entirely to the wholly unsatisfied performance obligations. Refer to Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025 for more information about our remaining performance obligations.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2025
(Unaudited)
Sales of Financing Receivables
We offer certain of our customers the option to acquire certain of our products and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $307 million and $1.1 billion for the three and six months ended November 30, 2025, respectively, and $266 million and $861 million for the three and six months ended November 30, 2024, respectively.
Non-Marketable Investments
Our non-marketable debt investments and equity securities and related instruments totaled $416 million and $2.1 billion as of November 30, 2025 and May 31, 2025, respectively, and are included in other non-current assets in the accompanying condensed consolidated balance sheets and are subject to periodic credit losses and impairment reviews. Certain of these non-marketable equity securities and related instruments are adjusted for observable price changes from orderly transactions. The majority of the non-marketable debt and equity investments we held as of May 31, 2025 were with Ampere Computing Holdings LLC (Ampere), an equity method investee. On March 19, 2025, SoftBank Group Corp. announced that it entered into an agreement with Ampere and its equity holders to acquire all of the equity interests of Ampere (the Ampere Acquisition). On November 25, 2025, the Ampere Acquisition was consummated and we received cash proceeds of $4.3 billion in exchange for our equity, debt and call option interests in Ampere. We recorded $2.7 billion of realized gain, which is included in the non-operating income, net line item in our condensed consolidated statements of operations for the three and six months ended November 30, 2025. We have no remaining investment in Ampere as of November 30, 2025.
Acquisition Related and Other Expenses
Acquisition related and other expenses primarily consist of personnel-related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net.
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2025
2024
2025
2024
Transitional and other employee-related costs
Business combination adjustments, net
(1
(5
Other, net
20
31
29
46
Total acquisition related and other expenses
21
31
35
44
Non-Operating Income, net
Non-operating income, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan), net gains and losses related to marketable and non-marketable investments, including net gains and losses attributable to equity method investments (primarily Ampere) and net other income and expenses, including net gains and losses from our investment portfolio related to our deferred compensation plan, for which an equal and offsetting amount was recorded to our operating expenses during the same period, and non-service net periodic pension income and losses.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2025
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2025
2024
2025
2024
Interest income
192
149
295
283
Foreign currency losses, net
(28
(9
(59
(59
Noncontrolling interests in income
(46
(47
(93
(90
Gains (losses) from marketable and non-marketable investments, net
2,493
(108
2,441
(177
Other income, net
57
51
157
100
Total non-operating income, net
2,668
36
2,741
57
Recent Accounting Pronouncements
Income Taxes: In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which enhances the disclosures required for income taxes in our annual consolidated financial statements. ASU 2023-09 is effective for us for our annual reporting for fiscal 2026 on a prospective basis. Both early adoption and retrospective application are permitted. We are currently evaluating the impact of our pending adoption of ASU 2023-09 on our consolidated financial statements.
Income Statement: In November 2024, the FASB issued ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and also issued subsequent guidance clarifying the effective date of the initial guidance (collectively, Subtopic 220-40), which enhances the disclosures required for expense disaggregation in our annual and interim consolidated financial statements. This guidance is effective for us for our annual reporting for fiscal 2028 and for interim period reporting beginning in fiscal 2029 on a prospective basis. Both early adoption and retrospective application are permitted. We are currently evaluating the impact of our pending adoption of Subtopic 220-40 on our consolidated financial statements.
Software Development Costs: In September 2025, the FASB issued ASU 2025-06, Intangibles Goodwill and Other Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06), which clarifies and modernizes the accounting for internal-use software. ASU 2025-06 is effective for us in the first quarter of fiscal 2029, with early adoption permitted. The standard permits application of the guidance using a prospective, retrospective, or modified transition approach. We are currently evaluating the impact of our pending adoption of ASU 2025-06 on our consolidated financial statements.
2.FAIR VALUE MEASUREMENTS
We perform fair value measurements in accordance with FASB Accounting Standards Codification (ASC) 820, Fair Value Measurement (ASC 820). ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions and risk of nonperformance.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2025
(Unaudited)
ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset s or a liability s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
Level 1: quoted prices in active markets for identical assets or liabilities;
Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or
Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1 and Level 2 inputs are defined above):
November 30, 2025
May 31, 2025
Fair Value Measurements
Using Input Types
Fair Value Measurements
Using Input Types
(in millions)
Level 1
Level 2
Total
Level 1
Level 2
Total
Assets:
Money market funds
11,834
11,834
2,220
2,220
Time deposits and other
66
506
572
59
526
585
Derivative financial instruments
21
21
54
54
Total assets
11,900
527
12,427
2,279
580
2,859
Liabilities:
Derivative financial instruments
26
26
Our cash equivalents and marketable securities investments consist of money market funds, time deposits and marketable equity securities. Marketable securities as presented per our condensed consolidated balance sheets included debt securities with original maturities at the time of purchase greater than three months and the remainder of the debt securities were included in cash and cash equivalents. We classify our marketable debt securities as available-for-sale debt securities at the time of purchase and reevaluate such classification as of each balance sheet date. As of November 30, 2025 and May 31, 2025, all of our marketable debt securities investments mature within one year. Our valuation techniques used to measure the fair values of our instruments that were classified as Level 1 in the table above were derived from quoted market prices and active markets for these instruments that exist. Our valuation techniques used to measure the fair values of Level 2 instruments listed in the table above were derived from the following: non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques, with all significant inputs derived from or corroborated by observable market data including reference rate yield curves, among others.
Based on the trading prices of the $106.1 billion and $90.3 billion of senior notes and other long-term borrowings and the related fair value hedges, if any, that we had outstanding as of November 30, 2025 and May 31, 2025, respectively, the estimated fair values of the senior notes and other long-term borrowings and the related fair value hedges, if any, using Level 2 inputs at November 30, 2025 and May 31, 2025 were $95.8 billion and $81.3 billion, respectively.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2025
(Unaudited)
3.NOTES PAYABLE AND OTHER BORROWINGS
Senior Notes
In September 2025, we issued $18.0 billion par value of fixed-rate senior notes comprising the following:
November 30, 2025
(Dollars in millions)
Amount
Effective
Interest
Rate
$3,000, 4.45%, due September 2030
3,000
4.55%
$3,000, 4.80%, due September 2032
3,000
4.87%
$4,000, 5.20%, due September 2035
4,000
5.25%
$2,500, 5.875%, due September 2045
2,500
5.91%
$3,500, 5.95%, due September 2055
3,500
6.05%
$2,000, 6.10%, due September 2065
2,000
6.17%
Total fixed-rate senior notes
18,000
Unamortized discount/issuance costs
(118
Total fixed-rate senior notes, net
17,882
We issued the senior notes for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions and payment of cash dividends on or repurchases of our common stock. The interest is payable semi-annually. We may redeem some or all of the senior notes of each series prior to their maturity, subject to certain restrictions and the payment of an applicable make-whole premium in certain instances.
The senior notes rank pari passu with any other existing and future unsecured and unsubordinated indebtedness of Oracle. All existing and future indebtedness and liabilities of the subsidiaries of Oracle are or will be effectively senior to the senior notes. We were in compliance with all senior notes-related covenants as of November 30, 2025. The other terms and conditions of the senior notes are set forth in, and the foregoing description of the senior notes is qualified in its entirety by reference to, the Officers Certificate filed herewith as Exhibit 4.01 and incorporated by reference herein.